Antibiotic-resistant infections killed nearly 30,000 people in 2020—a 15% increase from the year before. A new report from the Centers for Disease Control and Prevention explores the effect that the coronavirus pandemic has had on the growing superbug threat.
Since 2017, only 12 new antibiotics have been approved, and 10 of them belong to existing classes that already face resistance. It's high time to fix the broken antibiotics market—before it's too late.
Antibiotic-resistant bacteria caused more deaths in 2019 than HIV or malaria, and the threat is growing. If passed, though, the PASTEUR Act will encourage innovation of new antibiotics—and save lives. It's time for Congress to act.
Following the Food and Drug Administration's decision not to approve a new drug for antibiotic-resistant urinary tract infections, Spero Therapeutics was forced to lay off 75% of its employees.
In the face of mounting resistance and a lack of innovation, "what the world desperately needs is a new golden age of antibiotics," writes Henry B. Skinner, CEO of the Antimicrobial Resistance Action Fund.
Antibiotics are fundamental to modern medicine, essential for treating everything from routine skin infections to strep throat, and for protecting vulnerable patients receiving chemotherapy or being treated in intensive care units.
Pew's antibiotic resistance project is working to ensure both the prudent use of existing drugs and a robust pipeline of new drugs in order to meet current and future patient needs.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.